Sign inCreate account

Report workspace

Add to folder
NCT06820775NOT_YET_RECRUITINGanonymous

EFFECTIVENESS OF A TRIPLE NUTRITIONAL INTERVENTION AND PHYSICAL ACTIVITY FOR GLYCOSYLATED HB CONTROL IN PREDIABETICS: CLINICAL TRIAL

Sponsor

Source record

Bioaraba Health Research Institute

Phase

Source record

Not Yet Recruiting

Modality

AI-normalized

combination therapy

Target

AI-normalized

Glycosylated hemoglobin (HbA1c) control through lifestyle modifications including dietary interventions and physical activity.

Indication / condition

AI-normalized

Diabetes

Intervention

Source record

A TRIPLE INTERVENTION NUTRITION AND PHYSICAL ACTIVITY

Related intelligence directories

Indication directory: DiabetesModality directory: combination therapyTarget directory: Glycosylated hemoglobin (HbA1c) control through lifestyle modifications including dietary interventions and physical activity.

Source & freshness

Source record

NCT ID

NCT06820775

Original source

ClinicalTrials.gov

Source last updated

Feb 11, 2025

Ingested at

Jun 19, 2026

Internal sync

Jun 19, 2026

Model version

trialsignal-ai-v1

Normalized confidence

96%

Validation status

validated

Open original registry record
View original source fields

NCT ID

NCT06820775

Title

EFFECTIVENESS OF A TRIPLE NUTRITIONAL INTERVENTION AND PHYSICAL ACTIVITY FOR GLYCOSYLATED HB CONTROL IN PREDIABETICS: CLINICAL TRIAL

Sponsor

Bioaraba Health Research Institute

Status

NOT_YET_RECRUITING

Phase

Not Yet Recruiting

Condition raw

Diabetes

Condition normalized

Diabetes

Modality raw

combination therapy

Modality normalized

combination therapy

Target raw

Glycosylated hemoglobin (HbA1c) control through lifestyle modifications including dietary interventions and physical activity.

Target normalized

Glycosylated hemoglobin (HbA1c) control through lifestyle modifications including dietary interventions and physical activity.

Interventions

A TRIPLE INTERVENTION NUTRITION AND PHYSICAL ACTIVITY

Public preview

Source record

The clinical trial sponsored by Bioaraba Health Research Institute aims to evaluate a triple intervention strategy for glycemic control in prediabetic patients, a population at high risk for developing diabetes. Given the increasing prevalence of diabetes globally, this trial addresses a significant market need. The intervention's focus on non-pharmacological approaches may appeal to healthcare systems seeking cost-effective solutions to manage prediabetes. The competitive landscape includes various lifestyle modification programs and pharmacological treatments for diabetes, necessitating a thorough diligence process to assess the trial's potential market positioning and reimbursement pathways.

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Early access offer

Subscribe with code FOUNDERS5 for a 5-day premium trial.

Full protocol, outcomes, eligibility, contacts and results sections
Patent/IP landscape with verified records when available
Board-ready PDF export with source provenance
Save to folders and synthesize multiple assets in premium workspace
Create account
Sign in

Create a free account first, then unlock a single report, buy credits or subscribe.

TrialSignal

Clinical trial intelligence report

EFFECTIVENESS OF A TRIPLE NUTRITIONAL INTERVENTION AND PHYSICAL ACTIVITY FOR GLYCOSYLATED HB CONTROL IN PREDIABETICS: CLINICAL TRIAL

Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.

Generated

Jun 19, 2026

NCT ID

NCT06820775

Status

NOT_YET_RECRUITING

Phase

Not Yet Recruiting

Sponsor

Bioaraba Health Research Institute

Executive brief

Investment-Ready Snapshot

The clinical trial sponsored by Bioaraba Health Research Institute aims to evaluate a triple intervention strategy for glycemic control in prediabetic patients, a population at high risk for developing diabetes. Given the increasing prevalence of diabetes globally, this trial addresses a significant market need. The intervention's focus on non-pharmacological approaches may appeal to healthcare systems seeking cost-effective solutions to manage prediabetes. The competitive landscape includes various lifestyle modification programs and pharmacological treatments for diabetes, necessitating a thorough diligence process to assess the trial's potential market positioning and reimbursement pathways.

Source & freshness

Provenance

SourceClinicalTrials.gov
Source updatedFeb 11, 2025
Internal syncJun 19, 2026
Model versiontrialsignal-ai-v1

https://clinicaltrials.gov/study/NCT06820775

Indication

Diabetes

Modality

combination therapy

Target

Glycosylated hemoglobin (HbA1c) control through lifestyle modifications including dietary interventions and physical activity.

Intervention

A TRIPLE INTERVENTION NUTRITION AND PHYSICAL ACTIVITY

Source record

Protocol Description

Detailed source ingestion pending.

Source record

Outcome Measures

Detailed source ingestion pending.

Source record

Eligibility

Detailed source ingestion pending.

AI analysis

Known Results And Readout Context

Detailed source ingestion pending.

IP intelligence

Patent And IP Landscape

Detailed source ingestion pending.

Source record

Contacts

Detailed source ingestion pending.